MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202641076872 A) filed by N. P. V. Susmitha; Lakshmi Sai Varshini Yedavalli; Dr L Salomi Sangeetha; Surapuraju Suneetha; Dr. L. Nagarajan; Mr. S. Aravinth; Mr. Jagadhish V S; Dr. Tayyaba Tabassum; Dr G Srinivas Reddy; K. Malarkodi; Urlam Pranita; and Ms. S Priyadharshini on June 22, 2026, for Ai-Assisted Smart Nanoparticle System For Early Prediction And Targeted Treatment Of Cervical Cancer.
Inventors include N. P. V. Susmitha; Lakshmi Sai Varshini Yedavalli; Dr L Salomi Sangeetha; Surapuraju Suneetha; Dr. L. Nagarajan; Mr. S. Aravinth; Mr. Jagadhish V S; Dr. Tayyaba Tabassum; Dr G Srinivas Reddy; K. Malarkodi; Urlam Pranita; and Ms. S Priyadharshini.
The application for the patent was published on July 03, 2026, under issue no. 27/2026.
Abstract: AI-Assisted Smart Nanoparticle System for Early Prediction and Targeted Treatment of Cervical Cancer is the proposed invention. The proposed system integrates multimodal clinical data, genomic biomarkers, HPV screening information, medical imaging, and patient health records using a Transformer-based deep learning framework to predict disease onset, progression, and treatment response. Based on AI-generated insights, personalized nanoparticles are engineered with tumor-targeting ligands and loaded with therapeutic agents for selective drug delivery. Stimuli-responsive release mechanisms enable controlled treatment within the tumor microenvironment while minimizing damage to healthy tissues. A reinforcement learning module continuously optimizes treatment strategies using real-time biomarker and imaging feedback. The invention enhances diagnostic accuracy, enables precision medicine, improves therapeutic efficacy, and supports personalized cervical cancer management through intelligent prediction, adaptive drug delivery, and explainable clinical decision support.
Disclaimer: Curated by HT Syndication.
